Table 1.
Prostate | Age | CLE Probe | In Vivo Imaging | Ex Vivo Imaging | Nerve Sparing | Gleason Score | Stage | ECE* |
---|---|---|---|---|---|---|---|---|
1 | 49 | 0.85-mm | Y | Y | Bilateral | 3+3, tertiary 4 | pT2c Nx | None |
2 | 57 | 0.85-mm | Y | Y | Bilateral | 3+4 | pT3a N0 | Focal |
3 | 65 | 0.85-mm | Y | Y | Bilateral | 3+3 | pT2a N0 | None |
4 | 57 | 0.85-mm | Y | Y | Bilateral | 3+4 | pT2a N0 | None |
5 | 70 | 2.6-mm | N | Y | Bilateral | 3+4 | pT2c N0 | None |
6 | 64 | 2.6-mm | Y | Y | Bilateral | 3+4 | pT2c N0 | None |
7 | 64 | 2.6-mm | Y | Y | Bilateral | 3+4 | pT3b N0 | Present |
8 | 66 | 2.6-mm | N | Y | Unilateral, right | 4+3 | pT2c N0 | None |
9 | 65 | 2.6-mm | N | Y | Bilateral | 4+3 | pT3b N0 | Focal |
10 | 53 | 2.6-mm | Y | Y | Unilateral, right | 3+4 | pT3a N0 | Focal |
11 | 57 | 2.6-mm | N | Y | Unilateral, left | 4+5 | pT3a N0 | Focal |
12 | 52 | 2.6-mm | Y | Y | Bilateral | 3+3, tertiary 4 | pT2c N0 | None |
13 | 63 | 2.6-mm | Y | Y | Bilateral | 3+4 | pT2b Nx | None |
14 | 66 | 2.6-mm | Y | Y | Bilateral | 3+3 | pT2b N0 | None |
15 | 67 | 2.6-mm | Y | Y | Bilateral | 3+4 | pT2c N0 | None |
16 | 65 | 2.6-mm | Y | Y | Unilateral, left | 4+3 | pT2a N0 | None |
17 | 65 | 2.6-mm | N | Y | Bilateral | 4+4 | pT3a N0 | Present |
18 | 69 | 2.6-mm | Y | Y | Unilateral, right | 4+4 | pT2a N0 | None |
19 | 59 | 2.6-mm | N | Y | Bilateral | 3+3 | pT2c N0 | None |
20 | 65 | 2.6-mm | Y | Y | Bilateral | 3+3, tertiary 4 | pT2c Nx | None |
21 | 67 | 2.6-mm | Y | N | Bilateral | 3+4 | pT2a N0 | None |
CLE, confocal laser endomicroscopy.
Extra capsular extension